Vorinostat and bortezomib as third-line therapy in patients with advanced non-small cell lung cancer: a Wisconsin Oncology Network Phase II study

Por Hoang, Tien, Campbell, Toby C., Zhang, Chong, Kim, KyungMann, Kolesar, Jill M., Oettel, Kurt R., Blank, Jules H., Robinson, Emily G., Ahuja, Harish G., Kirschling, Ron J., Johnson, Peter H., Huie, Michael S., Wims, Mary E., Larson, Martha M., Hernan, Hilary R., Traynor, Anne M.
Publicado no Invest New Drugs (2013)